← Back to all trials
Completed
NCT05734235
UVB-Induced MVP Release in Human Skin
Conditions: Ultraviolet B Radiation, Microvesicle Particles
Sex: Male
Ages: 21 Years – 45 Years
Healthy volunteers: 1
Phase: PHASE1
Enrollment: 8
Sponsor: Wright State University
Location: United States
Summary
This study is designed to assess if ultraviolet B radiation (UVB) found in sunlight causes the release of microvesicle particles in human skin, and if antioxidant vitamins can block their production.
Eligibility Criteria
Inclusion Criteria:Male subjectsAges 21 to 45Skin type: Fitzpatrick Type I or IIExclusion Criteria:Have underlying diseases that could affect wound healingOn medications that are known photosensitizers (e.g., doxycycline) or anti-inflammatories (e.g., NSAIDS [except for low-dose aspirin] or steroids)History of abnormal scarring (e.g., keloids)Should not be on Vitamin C or E supplements for past monthUnable to understand/complete informed consentLarge volar arm tattoos that would inhibit the ability to conduct/evaluate the skin testingRenal compromise/kidney stones or allergy to Vitamin C/Vitamin E or lidocaine anaestheticUse of tanning bends or recent UVB exposure to the areas in the past 3 monthsRecent (within 1 week) use to sunscreen to volar forearms
Source: ClinicalTrials.gov (NCT05734235). StuddyBuddy aggregates publicly available trial information.